KL-590586
- Generic Name
- KL-590586
A Study of EP0031 in Patients With Advanced RET-altered Malignancies
- First Posted Date
- 2022-07-05
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Ellipses Pharma
- Target Recruit Count
- 265
- Registration Number
- NCT05443126
- Locations
- 🇺🇸
David Geffen School of Medicine at UCLA, Los Angeles, California, United States
🇺🇸Georgetown University, Washington, District of Columbia, United States
🇺🇸Stanford University, Stanford, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath